Johan M. Spoor - Net Worth and Insider Trading
Johan M. Spoor Net Worth
The estimated net worth of Johan M. Spoor is at least $200 dollars as of 2024-05-21. Johan M. Spoor is the PRESIDENT AND CEO of Entero Therapeutics Inc and owns about 63 shares of Entero Therapeutics Inc (ENTO) stock worth over $180. Johan M. Spoor is also the CEO, PRESIDENT, CHAIRMAN of FluoroPharma Medical Inc and owns about 200,398 shares of FluoroPharma Medical Inc (FPMI) stock worth over $20. Details can be seen in Johan M. Spoor's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Johan M. Spoor has not made any transactions after 2018-12-28 and currently still holds the listed stock(s).
Transaction Summary of Johan M. Spoor
Johan M. Spoor Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Johan M. Spoor owns 5 companies in total, including Entero Therapeutics Inc (ENTO) , MetaStat Inc (MTST) , and FluoroPharma Medical Inc (FPMI) among others .
Click here to see the complete history of Johan M. Spoor’s form 4 insider trades.
Insider Ownership Summary of Johan M. Spoor
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTO | Entero Therapeutics Inc | 2018-12-28 | director & President and CEO |
| MTST | MetaStat Inc | 2014-12-31 | director |
| FPMI | FluoroPharma Medical Inc | 2014-01-07 | director & CEO & PRESIDENT & CHAIRMAN |
 | | 2013-02-15 | director |
| | 2023-02-03 | director & CEO |
Johan M. Spoor Latest Holdings Summary
Johan M. Spoor currently owns a total of 2 stocks. Among these stocks, Johan M. Spoor owns 63 shares of Entero Therapeutics Inc (ENTO) as of December 28, 2018, with a value of $180 and a weighting of 89.96%. Johan M. Spoor also owns 200,398 shares of FluoroPharma Medical Inc (FPMI) as of January 7, 2014, with a value of $20 and a weighting of 10.04%.
Latest Holdings of Johan M. Spoor
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTO | Entero Therapeutics Inc | 2018-12-28 | 63 | 2.85 | 180 |
| FPMI | FluoroPharma Medical Inc | 2014-01-07 | 200,398 | 0.00 | 20 |
Holding Weightings of Johan M. Spoor
Johan M. Spoor Form 4 Trading Tracker
According to the SEC Form 4 filings, Johan M. Spoor has made a total of 0 transactions in Entero Therapeutics Inc (ENTO) over the past 5 years. The most-recent trade in Entero Therapeutics Inc is the acquisition of 6 shares on December 28, 2018, which cost Johan M. Spoor around $50,158.
According to the SEC Form 4 filings, Johan M. Spoor has made a total of 0 transactions in FluoroPharma Medical Inc (FPMI) over the past 5 years. The most-recent trade in FluoroPharma Medical Inc is the acquisition of 10,000 shares on January 7, 2014, which cost Johan M. Spoor around $5,000.
Insider Trading History of Johan M. Spoor
- 1
Johan M. Spoor Trading Performance
GuruFocus tracks the stock performance after each of Johan M. Spoor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Johan M. Spoor is 17.83%. GuruFocus also compares Johan M. Spoor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Johan M. Spoor within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Johan M. Spoor's insider trading performs compared to the benchmark.
Performance of Johan M. Spoor
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.77 | | | | | |
| Relative Return to S&P 500(%) | 3.76 | | | | | |
Johan M. Spoor Ownership Network
Johan M. Spoor Owned Company Details
What does Entero Therapeutics Inc do?
Who are the key executives at Entero Therapeutics Inc?
Johan M. Spoor is the director & President and CEO of Entero Therapeutics Inc. Other key executives at Entero Therapeutics Inc include director & President and CEO James Sapirstein , Chief Financial Officer Sarah Romano , and CHIEF FINANCIAL OFFICER Daniel H Schneiderman .
Entero Therapeutics Inc (ENTO) Insider Trades Summary
Over the past 18 months, Johan M. Spoor made no insider transaction in Entero Therapeutics Inc (ENTO). Other recent insider transactions involving Entero Therapeutics Inc (ENTO) include a net sale of 8,338 shares made by James Sapirstein , a net sale of 4,944 shares made by Sarah Romano , and a net sale of 6,063 shares made by Charles J Casamento .
In summary, during the past 3 months, insiders sold 3,256 shares of Entero Therapeutics Inc (ENTO) in total and bought 0 shares, with a net sale of 3,256 shares. During the past 18 months, 4,311 shares of Entero Therapeutics Inc (ENTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,311 shares.
Entero Therapeutics Inc (ENTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entero Therapeutics Inc Insider Transactions
Johan M. Spoor Mailing Address
Above is the net worth, insider trading, and ownership report for Johan M. Spoor. You might contact Johan M. Spoor via mailing address: 500 Boylston Street, Suite 1600, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
